Duration of positive urine for cocaine metabolite after ophthalmic administration: Implications for testing patients with suspected Horner syndrome using ophthalmic cocaine

American Journal of Ophthalmology

Volumn 131, Issue 6, 2001, Pages 742-747

  Jacobson, Daniel M ^a   Berg, Richard ^a   Grinstead, Gregory F ^a   Kruse, Jodene R ^a  

^a MARSHFIELD CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOYLECGONINE; COCAINE; CREATININE; DRUG METABOLITE;

ACCURACY; ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; CREATININE URINE LEVEL; DRUG DETERMINATION; DRUG IDENTIFICATION; FEMALE; GAS CHROMATOGRAPHY; HORNER SYNDROME; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; ORGANIZATION; PRIORITY JOURNAL; URINALYSIS;

ADULT; COCAINE; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HORNER SYNDROME; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; OPHTHALMIC SOLUTIONS; OSMOLAR CONCENTRATION; SYMPATHOMIMETICS; TIME FACTORS;

EID: 0034994791     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(00)00945-4     Document Type: Article

References (16)

1. Kardon RH, Denison CE, Brown CK, Thompson HS. Critical evaluation of the cocaine test in the diagnosis of Homer's syndrome. Arch Ophthalmol 1990;108:384-387.
2. Cone EJ. Pharmacokinetics and pharmacodynamics of cocaine. J Anal Toxicol 1995;19:459-478.
3. Cone EJ, Tsadik A, Oyler J, Darwin WD. Cocaine metabolism and urinary excretion after different routes of administration. Ther Drug Monit 1998;20:556-560.
4. Preston KL, Silverman K, Schuster CR, Cone EJ. Use of quantitative urinalysis in monitoring cocaine use. NIDA Research Monograph 1997;175:253-264.
5. Bralliar BB, Skarf B, Owens JB. Ophthalmic use of cocaine and the urine test for benzoylecgonine. N Engl J Med 1989;320:1757-1758.
6. Jenkins AJ. Forensic drug testing. In: Levine B, editor. Principles of forensic toxicology. Washington, DC: American Association for Clinical Chemistry, 1999:31-45.
7. Henderson DR, Friedman SB, Harris KD, Manning WB, Zoccoli MA. CEDIA, a new homogeneous immunoassay system. Clin Chem 1986;32:1637-1641.
8. CEDIA DAU. Cocaine assay package insert. Boehringer Mannheim Corporation, Indianapolis, Indiana.
9. Chinn DM, Crouch DJ, Peat MA, Finkle BS, Jennison TA. Gas chromatography-chemical ionization mass spectrometry of cocaine and its metabolites in biologic fluids. J Anal Toxicol 1980;4:37-42.
10. Mule SJ, Casella GA. Confirmation of marijuana, cocaine, morphine, codeine, amphetamine, methamphetamine, phencyclidine by GC/MS in urine following immunoassay screening. J Anal Toxicol 1988;12:102-107.
11. Butler AR. The Jaffe reaction: identification of the coloured species. Clin Chim Acta 1976;59:227-232.
12. Cone EJ, Lange R, Darwin WD. In vivo adulteration: excess fluid ingestion causes false-negative marijuana and cocaine urine tests. J Anal Toxicol 1998;22:460-473.
13. SAS Institute, Inc. SAS technical report P-229: the MIXED procedure. SAS Institute, Inc: Cary, North Carolina, 1992.
14. National Center for Health Statistics. Anthropometric reference data and prevalence of overweight, United States, 1976-1980. Hyattsville, MD: National Center for Health Statistics, 1987: DHHS Publication No. (PHS) 87-1688.
15. Osterloh J. Drug testing in the workplace. Occupational Med 1990;5:617-632.
16. Gerson B, Subramaniam S. Drug testing as part of the war on drugs. Clin Lab Med 1998;18:781-803.